Literature DB >> 21339753

Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation.

C-H Chiang, Y Su, Z Wen, N Yoritomo, C A Ross, R L Margolis, H Song, G-L Ming.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21339753      PMCID： PMC4005725          DOI： 10.1038/mp.2011.13

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  10 in total

Review 1.  Neurobiology of schizophrenia.

Authors:  Christopher A Ross; Russell L Margolis; Sarah A J Reading; Mikhail Pletnikov; Joseph T Coyle
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

2.  Association within a family of a balanced autosomal translocation with major mental illness.

Authors:  D St Clair; D Blackwood; W Muir; A Carothers; M Walker; G Spowart; C Gosden; H J Evans
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

3.  Implications of normal brain development for the pathogenesis of schizophrenia.

Authors:  D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1987-07

4.  Disruption of two novel genes by a translocation co-segregating with schizophrenia.

Authors:  J K Millar; J C Wilson-Annan; S Anderson; S Christie; M S Taylor; C A Semple; R S Devon; D M St Clair; W J Muir; D H Blackwood; D J Porteous
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

Review 5.  Schizophrenia: a common disease caused by multiple rare alleles.

Authors:  Jon M McClellan; Ezra Susser; Mary-Claire King
Journal:  Br J Psychiatry       Date:  2007-03       Impact factor: 9.319

6.  A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder.

Authors:  N A Sachs; A Sawa; S E Holmes; C A Ross; L E DeLisi; R L Margolis
Journal:  Mol Psychiatry       Date:  2005-08       Impact factor: 15.992

Review 7.  The DISC locus in psychiatric illness.

Authors:  J E Chubb; N J Bradshaw; D C Soares; D J Porteous; J K Millar
Journal:  Mol Psychiatry       Date:  2007-10-02       Impact factor: 15.992

8.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

9.  DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms.

Authors:  Kenji Nakata; Barbara K Lipska; Thomas M Hyde; Tianzhang Ye; Erin N Newburn; Yukitaka Morita; Radhakrishna Vakkalanka; Maxim Barenboim; Yoshitatsu Sei; Daniel R Weinberger; Joel E Kleinman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-02       Impact factor: 11.205

10.  Disease-specific induced pluripotent stem cells.

Authors:  In-Hyun Park; Natasha Arora; Hongguang Huo; Nimet Maherali; Tim Ahfeldt; Akiko Shimamura; M William Lensch; Chad Cowan; Konrad Hochedlinger; George Q Daley
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582
  10 in total
  85 in total

1.  Robust Hi-C Maps of Enhancer-Promoter Interactions Reveal the Function of Non-coding Genome in Neural Development and Diseases.

Authors:  Leina Lu; Xiaoxiao Liu; Wei-Kai Huang; Paola Giusti-Rodríguez; Jian Cui; Shanshan Zhang; Wanying Xu; Zhexing Wen; Shufeng Ma; Jonathan D Rosen; Zheng Xu; Cynthia F Bartels; Riki Kawaguchi; Ming Hu; Peter C Scacheri; Zhili Rong; Yun Li; Patrick F Sullivan; Hongjun Song; Guo-Li Ming; Yan Li; Fulai Jin
Journal:  Mol Cell       Date:  2020-06-26       Impact factor: 17.970

Review 2.  Cellular reprogramming: recent advances in modeling neurological diseases.

Authors:  Guo-Li Ming; Oliver Brüstle; Alysson Muotri; Lorenz Studer; Marius Wernig; Kimberly M Christian
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 3.  Neural stem cells: mechanisms and modeling.

Authors:  Jun Yao; Yangling Mu; Fred H Gage
Journal:  Protein Cell       Date:  2012-05-02       Impact factor: 14.870

Review 4.  Programming and reprogramming neuronal subtypes in the central nervous system.

Authors:  Caroline Rouaux; Salman Bhai; Paola Arlotta
Journal:  Dev Neurobiol       Date:  2012-07       Impact factor: 3.964

Review 5.  Cellular reprogramming: a novel tool for investigating autism spectrum disorders.

Authors:  Kun-Yong Kim; Yong Wook Jung; Gareth J Sullivan; Leeyup Chung; In-Hyun Park
Journal:  Trends Mol Med       Date:  2012-07-06       Impact factor: 11.951

Review 6.  Induced pluripotent stem cells for modeling neurological disorders.

Authors:  Fabiele B Russo; Fernanda R Cugola; Isabella R Fernandes; Graciela C Pignatari; Patricia C B Beltrão-Braga
Journal:  World J Transplant       Date:  2015-12-24

Review 7.  Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia.

Authors:  Kristen J Brennand; Fred H Gage
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

Review 8.  iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls.

Authors:  Daria Prilutsky; Nathan P Palmer; Niklas Smedemark-Margulies; Thorsten M Schlaeger; David M Margulies; Isaac S Kohane
Journal:  Trends Mol Med       Date:  2013-12-24       Impact factor: 11.951

Review 9.  Will brain cells derived from induced pluripotent stem cells or directly converted from somatic cells (iNs) be useful for schizophrenia research?

Authors:  Cheryl Filippich; Ernst J Wolvetang; Bryan J Mowry
Journal:  Schizophr Bull       Date:  2013-07-24       Impact factor: 9.306

Review 10.  Induced pluripotent stem cells: the new patient?

Authors:  Milena Bellin; Maria C Marchetto; Fred H Gage; Christine L Mummery
Journal:  Nat Rev Mol Cell Biol       Date:  2012-10-04       Impact factor: 94.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.